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Abstract
Traveller’s diarrhoea (TD) is the most common illness reported in international travellers. TD is caused by a wide range of pathogens,
including bacteria, viruses and parasites. Multiplex PCR assays can be especially useful for studying the aetiology of TD. The ﬁrst objective of
this study was to evaluate the utility of the commercially available multiplex PCR (xTAG Gastrointestinal Pathogen Panel (GPP)) for the
diagnosis of TD. A total of 185 stool specimens obtained from 174 patients were processed using the GPP assay. This test detected 86
pathogens in 67 stool samples (67/185, 36.2%). Sixteen pathogens out of 86 were also detected by routine testing. The remaining pathogens
(n = 70) required further conﬁrmation by alternative techniques. Finally, 60 out of 70 pathogens were conﬁrmed. The second objective of
this study was to analyse the aetiology of TD based on the results obtained by the GPP test and routine methods. The primary pathogens
causing TD were Shigella (24.2%) followed by enterotoxigenic Escherichia coli (ETEC) (23.2%), enteroaggregative E. coli (14.7%) and Giardia
(13.7%). Signiﬁcant regional differences were observed for ETEC with 19.4% of TD cases acquired in Africa, 11.3% in Asia and none in South
Central (SC) America (p 0.01), Giardia was found in 1.5% of cases among those who had travelled to Africa, 14.1% of those who had
travelled to Asia and 3% of those who had travelled to SC America (p 0.01). In conclusion, the GPP test improved the detection of
enteropathogens and allowed better assessment of the aetiology of TD.
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Introduction
Traveller’s diarrhoea (TD) is the most common illness
reported in international travellers. It is especially frequent
among people visiting tropical and subtropical regions [1,2].
Acute gastroenteritis is associated with bacterial, viral and
parasitic infections. The wide range of pathogens causing TD
makes it difﬁcult to predict a speciﬁc aetiology and select an
appropriate diagnostic method. The diagnosis of TD is usually
obtained through a combination of multiple tests, including
culture, molecular biology (mainly PCR), microscopy, rapid
antigen detection tests, etc. The main features of an optimal
test to diagnose infectious diseases are the following: the test
should be rapid (a few hours), inexpensive, highly sensitive and
speciﬁc, and easy to perform. In addition, the same test should
allow the detection of all predominant microorganisms causing
a speciﬁc syndrome. Recently, multiplex PCR assays have been
demonstrated to be more sensitive and to improve the
diagnosis of infectious gastroenteritis compared with classical
microbiological techniques [3–6]. The advantages of multiplex
PCR include the ability to detect co-infections and/or micro-
organisms that cannot be cultured.
The xTAG Gastrointestinal Pathogen Panel (GPP) (Lum-
inex Molecular Diagnostics, Toronto, ON, Canada) allows
rapid, simultaneous detection of the 15 most common
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gastroenteritis-causing agents. This assay is based on ampliﬁ-
cation of different bacterial, viral and parasitic targets, followed
by their subsequent detection by hybridization with tar-
get-speciﬁc bead populations and ﬂuorescence signal detection
with the Luminex instrument.
This study had two objectives: the ﬁrst was to evaluate the
utility of the GPP test for the diagnosis of TD, and the second
was to analyse the aetiology of TD using the combination of
this multiplex PCR assay and routine methods.
Materials and Methods
Sample collection
One hundred and eighty-ﬁve stool samples were collected in
our laboratory from November 2011 to November 2012.
Only samples obtained from patients with TD visiting the
Tropical Medicine Unit or the Emergency Department of the
Hospital Clınic, Barcelona, were included in the study.
Traveller’s diarrhoea was deﬁned as the occurrence of three
or more episodes of watery stools in 24 h from 12 h after
arrival in and 5 days after departure from the country visited,
with or without other symptoms, or the occurrence of
unformed stools accompanied by at least one of the following:
vomiting, nausea, abdominal pain, chills or fever. All patients
with TD were divided into four groups in accordance with the
geographical destination of the journey: South and Central
America, including the Caribbean (SC America); Africa; Asia;
and other destinations. An aliquot of each stool specimen was
stored at 80°C until processed by the GPP test. Samples
were prospectively assayed to detect enteropathogens using
routine methods in accordance with the clinician’s request, and
retrospectively using the GPP assay.
Routine microbiological techniques
All the samples included (n = 185) were processed for
bacterial study and almost all (n = 178) for parasitological
study. It must be emphasized that there was no clinician
request for virus and C. difﬁcile testing for any sample
processed as TD, although these targets were analysed with
the GPP assay.
The following media were used for bacterial culture: CCDA
agar plate (Oxoid, Basingstoke, UK) for Campylobacter isola-
tion, SS agar plate (Becton Dickinson, Heidelberg, Germany)
for Shigella and Salmonella, and CIN agar plate (Oxoid) for
Yersinia. In addition, a Rappaport-Vassiliadis Salmonella Enrich-
ment Broth (VWK Chemicals, MerckKGaA, Darmstadt, Ger-
many) was used as an enrichment step for the recovery of
Salmonella, followed by plating onto SS agar. Blood agar and
MacConkey agar plates were also used for each specimen.
Final identiﬁcation of bacteria was performed using MAL-
DI-TOF (matrix-assisted laser desorption/ionization time-of--
ﬂight mass spectrometry) (Bruker, Bremen, Germany) for
Campylobacter, Salmonella, Yersinia and E. coli. Salmonella and
Shigella isolated from stool samples were serotyped by
agglutination with commercial antisera (Bio-Rad, Mar-
nes-la-Coquette, France). Bloody stool samples were also
inoculated onto Sorbitol MacConkey agar plate for detection
of enterohaemorrhagic E. coli (EHEC) O157:H7. Two in-house
multiplex PCR assays were used for the detection of virulence
genes of diarrhoeagenic E. coli, including the target of the
CVD432 probe for enteroaggregative E. coli (EAEC), the lt and
st genes of enterotoxigenic E. coli (ETEC), and the stx1 and
stx2 genes for Shiga-like toxin producing E. coli (STEC). For the
extraction, several colonies of E. coli grown on MacConkey
agar were suspended in 50 lL of sterile water, followed by a
boiling step of 10 min. Afterwards, the tube was centrifuged
for 1 min at 16 000 g and the supernatant was used for PCR
assays. Ampliﬁcation was performed using the QuantiTect
Multiplex PCR Kit (Qiagen, Hilden, Germany) and previously
published primers [7–10]. Ampliﬁed products were detected
by electrophoresis on a 1% agarose gel.
For the detection of oxidase-positive Gram-negative bacilli
(GNB) such as Vibrio, Plesiomonas and Aeromonas, an oxidase
test was performed on the GNB colonies grown on blood
agar. Final identiﬁcation was achieved using MALDI-TOF.
Parasite detection involved microscopy directly from fresh
and concentrated (merthiolate formalin ether method) stool
samples, and the modiﬁed Kinyoun acid-fast stain for the
diagnosis of Cryptosporidium and Cyclospora cayetanensis. In
order to differentiate pathogenic Entamoeba histolytica from
non-pathogenic E. dispar detected by microscopy, a conven-
tional in-house PCR assay was performed, using previously
described primers [11].
GPP testing
All the stool samples collected were tested using the GPP
multiplex PCR assay for the detection of bacteria (Salmonella
spp.; Shigella spp., including S. dysenteriae, S. sonnei, S. boydii
and S. ﬂexneri; Campylobacter spp., including C. jejuni, C. coli and
C. lari; Vibrio cholerae; Yersinia enterocolitica; enterotoxigenic
Escherichia coli (ETEC); Shiga-like toxin producing E. coli stx1/
stx2 (STEC); E. coli O157; Clostridium difﬁcile toxin A/B), viruses
(rotavirus A, adenovirus serotypes 40/41, norovirus GI and
GII) and parasites (Giardia intestinalis, Entamoeba histolytica and
Cryptosporidium spp., including C. parvum and C. hominis).
Brieﬂy, 100 lL of stool specimen and 10 lL of an internal
control, E. coli phage MS2, were added to 1 mL of NucliSENS
easyMAG Lysis Buffer (BioMerieux, Marcy l’Etoile, France) in
a pre-treatment bead tube (Bertin SK38 Soil Kit bead tubes;
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Bertin Technologies, Montigny, France). After 5 min of
agitation by vortex, 10–15 min incubation at room tempera-
ture and centrifugation at 16 000 g for 2 min, 200 lL of the
supernatant were used for the automatic extraction with the
EZ1 Virus Mini Kit (Qiagen). The nucleic acids extracted were
recovered in 60 lL of elution buffer AVE. As a strategy to
avoid PCR inhibition, all the samples extracted were diluted
1:10 with RNase-free water prior to ampliﬁcation.
Multiplex RT-PCR reaction and hybridization steps were
performed in accordance with the manufacturer’s instructions.
Ten microlitres of extracted nucleic acid were used for each
RT-PCR reaction. At least one negative control was included
for each run. If the hybridization step was not performed
immediately, ampliﬁed products were stored at 2–5°C for a
maximum of 12 h. During the hybridization each Luminex bead
population detects a speciﬁc bacterial, viral or parasitic target
and/or internal control. The MAGPIX instrument (Luminex
Molecular Diagnostics) was used to read the ﬂuorescence
generated for each bead population. The data were analysed
with the xTAG Data Analysis Software for the Gastrointestinal
Pathogen Panel (TDAS GPP).
Conﬁrmation testing
Discordant samples that were positive for pathogens included
in the GPP panel and negative by the routine methods were
conﬁrmed using alternative techniques available in our labo-
ratory as mentioned below. Samples remaining unconﬁrmed
after this testing as well as those positive only by the GPP assay
for Giardia, E. histolytica, STEC, E. coli O157 and Campylobacter,
were sent to Luminex Molecular Diagnostics for conﬁrmation
by conventional PCR and bidirectional sequencing using
validated primers targeting genomic regions distinct from
those of the GPP test.
For conﬁrmation of Shigella, an in-house conventional PCR
with primers designed to amplify the inv locus, carried on a
large plasmid, were used [12]. This plasmid is present in all
virulent strains of the four Shigella species as well as in
enteroinvasive E. coli. PCR was performed using commercially
available reagents. Ampliﬁcation products were detected by
electrophoresis on a 1% agarose gel. To conﬁrm discordant
ETEC, the routine multiplex in-house PCR described above
was performed for the detection of lt and st genes using nucleic
acids extracted for the GPP test. Positive C. difﬁcile toxin
results were conﬁrmed using an immunochromatography
technique (ICT), Clostridium Difﬁcile Duo Toxin A+B (Monlab
Test, VEDALAB, Alencon, France). Norovirus conﬁrmation
was carried out using the MutaPLATE Norovirus real-time
RT-PCR Kit (Immundiagnostik AG, Bensheim, Germany)
whereas Rotavirus A was conﬁrmed using ICT VIKIA
Rota-Adeno (BioMerieux).
Statistical analysis
The regional differences found per pathogen detected were
compared using the Fisher exact test and were considered
statistically signiﬁcant with a p-value <0.05. The Stata12
software package (Stata (Release 12, Statistical Software);
StataCorp LP, College Station, TX, USA) was used for
statistical analysis.
Results
At the beginning of the study we obtained a large number of
inhibited results. Taking this into account and in accordance
with the manufacturer’s recommendations the following
additional step was added to the GPP assay protocol: all
extracted samples were diluted 1:10 in water prior to the
ampliﬁcation. Previously inhibited samples were retested, and
only four showed inhibition, not resolved with the dilution
step. These four samples were negative by routine testing and
excluded from the ﬁnal analysis. No further inhibited results
were obtained.
A total of 185 stool samples were included in the study. The
GPP test detected 86 pathogens in 67 stool samples (67/185,
36.2%). Sixteen pathogens out of 86 were also detected by
routine testing. The remaining pathogens (n = 70) required
further conﬁrmation by the alternative techniques described
above. After the conﬁrmation testing, 10 out of the 70
pathogens remained unconﬁrmed: eight pathogens had nega-
tive results (one E. histolytica, two Giardia, three ETEC, one
Shigella and one norovirus), whereas two could not be
conﬁrmed due to the lack of sample (two ETEC). Considering
unconﬁrmed results as negative, the ﬁnal data were: among the
185 samples included, the GPP test detected 76 pathogens in
59 stool samples (59/185, 31.9%). Therefore, the GPP test
detected 60 additional pathogens that conventional methods
failed to detect or that were not requested by the clinician.
The summary of GPP positive results before and after
conﬁrmation testing is shown in Table 1.
Apart from the 16 pathogens detected by both routine and
GPP testing, conventional methods identiﬁed 19 additional
pathogens, which are not incorporated in the GPP panel (14
EAEC and ﬁve C. cayetanensis). Combining both methods, 95
pathogens were detected among 70 positive samples (70/185,
37.8%) obtained from 69 patients (Table 2). The primary
pathogens causing TD in our study were Shigella (23/95, 24.2%)
followed by ETEC (22/95, 23.2%), EAEC (14/95, 14.7%) and
Giardia (13/95, 13.7%).
Twenty co-infections were detected among 70 positive
samples when combining routine and GPP testing (20/70,
28.6%). The most common pathogens involved in co-infections
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were Shigella (15/20, 75%) followed by ETEC (8/20, 40%),
EAEC (7/20, 35%) and Giardia (6/20, 30%) (Table 3).
One hundred and eighty-ﬁve samples were obtained from
174 patients. Most of the patients had travelled to Asia (71/
174, 40.8%), followed by Africa (67/174, 38.5%) and South
Central America (SC America) (33/174, 19%). Only three
patients visited different regions in Europe or North America
(Malta, Ireland and the USA, respectively).
Regarding the geographical destination of travellers with
positive stool samples (n = 69), most had visited Africa (31/69,
44.9%), followed by Asia (28/69, 40.6%) and SC America (9/69,
13%). Only one patient with a Shigella and Giardia co-infection
had travelled to south Europe (Malta) and not to a developing
region.
Table 4 shows the detection rates of the speciﬁc pathogens
among travellers to different geographical destinations. Signif-
icant regional differences were observed for ETEC and Giardia
(p 0.01). The average rate of negative stool samples among
patients with TD was 60.3% (105 patients with negative results
out of 174 included), with no signiﬁcant difference between the
geographical areas visited.
Discussion
This study had two objectives: to evaluate the usefulness of the
GPP multiplex PCR assay for the diagnosis of TD and to study
the aetiology of TD based on the results of GPP and
conventional testing. Recently, several studies focusing on
the evaluation of the GPP panel have been published [13–15].
However, none of these were aimed at evaluating the utility of
the GPP test among the traveller population. In the present
study we demonstrated that the use of this test can improve
the diagnosis of TD. We found that all the pathogens detected
by conventional testing, except those not included in the GPP
panel, were also identiﬁed by the GPP test. On the other hand,
a large number of GPP positive results required additional
conﬁrmation (n = 70), and only 10 of these remained uncon-
ﬁrmed. Therefore, the GPP assay was able to detect 60
additional pathogens in our study population and, hence,
improved the diagnosis of TD.
The higher detection of bacterial pathogens with the GPP
test has been previously reported [14], although the major
bacterial pathogens detected differed in the present study. We
found that the GPP test was especially sensitive to the
detection of Shigella and ETEC. All Shigella were detected by
only the GPP assay. This could be for several reasons: a
TABLE 1. Summary of the results obtained regarding patho-
gens detected by the GPP test before and after conﬁrmation
testing
Pathogen
No. of pathogens detected
Before
conﬁrmation
testing (%)
After
conﬁrmation
testing (%)
ETEC 27 (31.4) 22 (29)
Shigella 24 (27.9) 23 (30.3)
Giardia intestinalis 15 (17.4) 13 (17.1)
Norovirus 6 (7) 5 (6.6)
Campylobacter 4 (4.6) 4 (5.3)
E. histolytica 3 (3.5) 2 (2.6)
Salmonella 2 (2.3) 2 (2.6)
C. difﬁcile toxin A/B 2 (2.3) 2 (2.6)
E. coli H7:O157 1 (1.2) 1 (1.3)
STEC stx1/stx2 1 (1.2) 1 (1.3)
Rotavirus A 1 (1.2) 1 (1.3)
Total 86 (100) 76 (100)
ETEC, enterotoxigenic E. coli; STEC, Shiga-like toxin producing E. coli.
TABLE 2. Summary of the results with conﬁrmed pathogens
detected by the GPP test and routine diagnostic methods
Pathogen
No. of pathogens detected
Only
routine
methods
Only the
GPP test Both
Total of
pathogens
detected (%)
Shigella 0 23 0 23 (24.2)
ETEC 0 18 4 22 (23.2)
EAEC 14 NI – 14 (14.7)
Giardia intestinalis 0 6 7 13 (13.7)
Norovirus NR 5 – 5 (5.2)
Cyclospora cayetanensis 5 NI – 5 (5.2)
Campylobacter 0 2 2 4 (4.2)
E. histolytica 0 1 1 2 (2.1)
Salmonella 0 0 2 2 (2.1)
C. difﬁcile toxin A/B NR 2 – 2 (2.1)
E. coli H7:O157 0 1 0 1 (1.1)
STEC stx1/stx2 0 1 0 1 (1.1)
Rotavirus A NR 1 – 1 (1.1)
Total 19 60 16 95 (100)
NR, tests not requested; NI, pathogens not included in the GPP panel; ETEC,
enterotoxigenic E. coli; EAEC, enteroaggregative E. coli; STEC, Shiga-like toxin
producing E. coli.
TABLE 3. Summary of samples with co-infections (n = 20)
detected using the GPP test and routine methods
No. of
samples
(n = 20)
Pathogens
detected
only by GPP
Pathogens detected
only by routine
methods
Pathogens
detected by
both methods
4a Shigella, ETEC – –
1 Shigella, Giardia – –
2 Shigella – Giardia
2 Shigella EAEC –
2 Norovirus EAEC –
1 Shigella, Giardia – Salmonella
1 Shigella, norovirus – –
1 Shigella, E. coli O157 – ETEC
1 Shigella, ETEC, Giardia – –
1 Shigella EAEC Giardia
1 Shigella, C. difﬁcile – –
1 ETEC – Salmonella
1 ETEC EAEC –
1 Campylobacter EAEC, C. cayetanensis –
aTwo samples co-infected with Shigella and ETEC were from the same patient.
ETEC, enterotoxigenic E. coli; EAEC, enteroaggregative E. coli.
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prolonged transportation time, previous antimicrobial therapy,
and a reduced sensitivity of the culture method for Shigella
detection compared with PCR techniques [16]. Moreover, we
could not exclude the possibility that some of the Shigella
detected were actually enteroinvasive E. coli (EIEC). As Shigella
and EIEC are closely related it is impossible to differentiate
between these pathogens using only molecular methods [17].
Nevertheless, given the previously reported low prevalence of
EIEC among patients with TD, we can expect that most of the
pathogens detected were Shigella species [18]. Regarding
ETEC, the high number of discordant results was probably due
to different sample processing in routine and GPP testing as
explained above.
The GPP test was also shown to be better at the
detection of parasites, especially Giardia, compared with
microscopy. Six conﬁrmed positive Giardia results that
routine microscopy failed to detect could be explained by
the low concentration of parasites in stool specimens.
Nevertheless, a reported low speciﬁcity of multiplex PCR
assays for parasite detection requires special attention
[19,20]. In our study two unconﬁrmed Giardia results were
detected in co-infected samples: one with ETEC and the
other with E. histolytica. This ﬁnding may be due to an
unspeciﬁc ampliﬁcation within the multiplex PCR. In addition,
only one of the two E. histolytica detected by the GPP test
and not by microscopy was conﬁrmed.
The GPP assay allowed the detection of unsuspected
enteric pathogens and, therefore, those not requested by
the clinician, including two C. difﬁcile, ﬁve norovirus, one
rotavirus, one Giardia and one E. histolytica. The role of
norovirus in TD is well known, although it is more frequently
reported during diarrhoea outbreaks. In the present study,
norovirus was demonstrated to be an important unsuspected
aetiological agent of TD. Furthermore, the signiﬁcance of
C. difﬁcile-associated diarrhoea among travellers needs to be
further evaluated. One of the two patients with a positive stool
sample had previously taken ciproﬂoxacin, and the other had
co-infection with Shigella. While the association between
C. difﬁcile infection and the consumption of ﬂuoroquinolones
has been previously demonstrated [21,22], the signiﬁcance of
C. difﬁcile and Shigella co-infection requires further study.
Similar to the previous study [23], bacterial pathogens were
the main infectious agents responsible for TD among Spanish
travellers. Except for the rate of Shigella infections, our results
corroborate the published data with respect to the frequency
of pathogens involved in TD and their distribution among
geographical areas [1,18,24–26]. It must be taken into consid-
eration that in many previous studies culture was the only
method used for Shigella detection [24,27,28]. The usefulness
of PCR-based tests for the diagnosis of Shigella infection among
travellers needs further evaluation.
Despite the signiﬁcant advantages of multiplex PCR assays,
they cannot include all the pathogens causing infectious
gastroenteritis. In the present study, conventional methods
identiﬁed a large number of EAEC (n = 14), one of the major
aetiological agents of TD [18,24], and C. cayetanensis (n = 5).
We also detected a high number of co-infections among our
patients when combining the results of the GPP and routine
methods. Nevertheless, more studies are needed to clarify the
real signiﬁcance of this ﬁnding and to correlate it with clinical
data.
As shown in previous studies, the GPP assay signiﬁcantly
reduces the turnaround time of sample testing [13–15]. The
GPP test takes about 5 h, as compared with 24–48 h for
culture, the most time-consuming of the conventional tech-
niques. The GPP assay allows microbiologists to provide
TABLE 4. Distribution of pathogens detected among travellers in accordance with geographical regions visited
Pathogen detected
Africa (n = 67)a Asia (n = 71)a SC America (n = 33)a
p Valueb
No. of
travellers %
No. of
travellers %
No. of
travellers %
ETEC 13 19.4 8 11.3 0 0 0.01
EAEC 6 8.9 5 7 3 9.1 0.87
EHEC 1 1.5 1 1.4 0 0 1.00
Shigella 10 14.9 10 14.1 1 3 0.18
Campylobacter 1 1.5 3 4.2 0 0 0.53
Salmonella 0 0 2 2.8 0 0 0.67
C. difﬁcile 0 0 1 1.4 1 3 0.50
Norovirus 3 4.5 2 2.8 0 0 0.62
Rotavirus 1 1.5 0 0 0 0 0.58
Giardia 1 1.5 10 14.1 1 3 0.01
E. histolytica 0 0 1 1.4 1 3 0.50
C. cayetanensis 1 1.5 1 1.4 3 9.1 0.11
No pathogen detected 36 53.7 43 60.6 24 72.7 0.19
aTotal number of travellers visiting a geographical region is indicated in parentheses.
bSigniﬁcant p values are indicated in bold.
SC America, South Central America; ETEC, enterotoxigenic E. coli; EAEC, enteroaggregative E. coli; EHEC, enterohaemorragic E. coli including Shiga-like toxin producing E. coli
and E. coli H7:O157.
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answers to the clinician in a single working day. This may be
very important for initiating appropriate antimicrobial treat-
ment or outbreak management.
Our study has several limitations. First, the number of
samples included was limited. Second, not all the samples
included were tested with the same range of conventional
methods. This makes comparative analysis between GPP and
routine testing difﬁcult. Therefore, we were also unable to
calculate the sensitivity and speciﬁcity of the GPP test for the
diagnosis of TD in the present study.
In summary, the GPP test was demonstrated to be useful
for the diagnosis of TD and could change our understanding of
the aetiology and the prevalence of some pathogens causing
TD. The impact on patient outcome or epidemiological
surveillance needs to be further evaluated.
Acknowledgements
All reagents for the xTAG GPP test were provided by
Luminex Molecular Diagnostics.
This study was supported by the Ministerio de Economıa y
Competitividad, Instituto de Salud Carlos III – co-ﬁnanced by
the European Development Regional Fund ‘A way to achieve
Europe’ ERDF, the Spanish Network for the Research in
Infectious Diseases (REIPI RD12/0015 and FIS 11/02024), and
by the grants 2009 SGR 1256 and 2009 SGR 385 from the
Departament d’Universitats, Recerca I Societat de la Inform-
acio of the Generalitat de Catalunya.
Transparency Declaration
The authors declare no conﬂicts of interest.
References
1. de la Cabada Bauche J, Dupont HL. New developments in traveler’s
diarrhea. Gastroenterol Hepatol 2011; 7: 88–95.
2. Baldi F, Bianco MA, Nardone G, Pilotto A, Zamparo E. Focus on acute
diarrhoeal disease. World J Gastroenterol 2009; 15: 3341–3348.
3. Coste JF, Vuiblet V, Moustapha B et al. Microbiological diagnosis of
severe diarrhea in kidney transplant recipients by use of multiplex PCR
assays. J Clin Microbiol 2013; 51: 1841–1849.
4. Amar CF, East CL, Gray J, Iturriza-Gomara M, Maclure EA, McLauchlin
J. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal
samples: re-examination of the English case-control Infectious Intestinal
Disease Study (1993–1996). Eur J Clin Microbiol Infect Dis 2007; 26: 311–
323.
5. Higgins RR, Beniprashad M, Cardona M, Masney S, Low DE, Gubbay JB.
Evaluation and veriﬁcation of the Seeplex Diarrhea-V ACE assay for
simultaneous detection of adenovirus, rotavirus, and norovirus
genogroups I and II in clinical stool specimens. J Clin Microbiol 2011;
49: 3154–3162.
6. Liu J, Gratz J, Maro A et al. Simultaneous detection of six diar-
rhea-causing bacterial pathogens with an in-house PCR-luminex assay. J
Clin Microbiol 2012; 50: 98–103.
7. Olsvik O, Strockbine NA. PCR Detection of heat-stable, heat-labile,
and Shiga-like toxin genes in Escherichia coli. In: Persing DH, Smith TF,
Tenover FC, White TJ, eds. Diagnostic molecular microbiology. Principles
and application. Rochester: Mayo Foundation, 1993: 271–276.
8. Lopez-Saucedo C, Cerna JF, Villegas-Sepulveda N et al. Single multiplex
polymerase chain reaction to detect diverse loci associated with
diarrheagenic Escherichia coli. Emerg Infect Dis 2003; 9: 127–131.
9. Nielsen EM, Andersen MT. Detection and characterization of verocy-
totoxin-producing Escherichia coli by automated 5’ nuclease PCR assay. J
Clin Microbiol 2003; 41: 2884–2893.
10. Aranda KR, Fagundes-Neto U, Scaletsky IC. Evaluation of multiplex
PCRs for diagnosis of infection with diarrheagenic Escherichia coli and
Shigella spp. J Clin Microbiol 2004; 42: 5849–5853.
11. Clark CG, Diamond LS. Differentiation of pathogenic Entamoeba
histolytica from other intestinal protozoa by riboprinting. Arch Med Res
1992; 23: 15–16.
12. Frankel G, Riley L, Giron JA et al. Detection of Shigella in feces using
DNA ampliﬁcation. J Infect Dis 1990; 161: 1252–1256.
13. Navidad JF, Griswold DJ, Gradus MS, Bhattacharyya S. Evaluation of
Luminex xTAG gastrointestinal pathogen analyte-speciﬁc reagents for
high-throughput, simultaneous detection of bacteria, viruses, and
parasites of clinical and public health importance. J Clin Microbiol
2013; 51: 3018–3024.
14. Mengelle C, Mansuy JM, Prere MF et al. Simultaneous detection of
gastrointestinal pathogens with a multiplex Luminex-based molecular
assay in stool samples from diarrhoeic patients. Clin Microbiol Infect
2013; 19: 458–465.
15. Kahlau P, Malecki M, Schildgen V et al. Utility of two novel multiplexing
assays for the detection of gastrointestinal pathogens – a ﬁrst
experience. Springerplus 2013; 2: 106.
16. Lindsay B, Ochieng JB, Ikumapayi UN et al. Quantitative PCR for
detection of Shigella improves ascertainment of Shigella burden in
children with moderate-to-severe diarrhea in low-income countries. J
Clin Microbiol 2013; 51: 1740–1746.
17. van den Beld MJ, Reubsaet FA. Differentiation between Shigella,
enteroinvasive Escherichia coli (EIEC) and noninvasive Escherichia coli.
Eur J Clin Microbiol Infect Dis 2012; 31: 899–904.
18. Vargas M, Gascon J, Gallardo F, Jimenez De Anta MT, Vila J. Prevalence
of diarrheagenic Escherichia coli strains detected by PCR in patients with
travelers’ diarrhea. Clin Microbiol Infect 1998; 4: 682–688.
19. Elsaﬁ SH, Al-Maqati TN, Hussein MI, Adam AA, Hassan MM, Al Zahrani
EM. Comparison of microscopy, rapid immunoassay, and molecular
techniques for the detection of Giardia lamblia and Cryptosporidium
parvum. Parasitol Res 2013; 112: 1641–1646.
20. Wessels E, Rusman LG, van Bussel MJ, Claas EC. Added value of
multiplex Luminex Gastrointestinal Pathogen Panel (xTAG GPP)
testing in the diagnosis of infectious gastroenteritis. Clin Microbiol Infect
2014; 20: 182–187.
21. Vernaz N, Hill K, Leggeat S et al. Temporal effects of antibiotic use and
Clostridium difﬁcile infections. J Antimicrob Chemother 2009; 63: 1272–
1275.
22. Aldape MJ, Packham AE, Nute DW, Bryant AE, Stevens DL. Effects of
ciproﬂoxacin on the expression and production of exotoxins by
Clostridium difﬁcile. J Med Microbiol 2013; 62: 741–747.
23. Gascon J, Vila J, Valls ME et al. Etiology of traveller’s diarrhea in
Spanish travellers to developing countries. Eur J Epidemiol 1993; 9: 217–223.
24. Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers’ diarrhea:
systematic review from 1973 to the present. Am J Trop Med Hyg 2009;
80: 609–614.
ª2014 The Authors
Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, O753–O759
O758 Clinical Microbiology and Infection, Volume 20 Number 10, October 2014 CMI
25. Adachi JA, Jiang ZD, Mathewson JJ et al. Enteroaggregative Escherichia
coli as a major etiologic agent in traveler’s diarrhea in 3 regions of the
world. Clin Infect Dis 2001; 32: 1706–1709.
26. Black RE. Epidemiology of travelers’ diarrhea and relative importance
of various pathogens. Rev Infect Dis 1990; 12 (suppl 1): 73–79.
27. Jiang ZD, Lowe B, Verenkar MP et al. Prevalence of enteric pathogens
among international travelers with diarrhea acquired in Kenya
(Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 2002;
185: 497–502.
28. Paredes P, Campbell-Forrester S, Mathewson JJ et al. Etiology of
travelers’ diarrhea on a Caribbean island. J Travel Med 2000; 7: 15–18.
ª2014 The Authors
Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, O753–O759
CMI Zboromyrska et al. Multiplex PCR for diagnosis of traveller’s diarrhoea O759
